Endeavour Medtech Growth II LP - 31 Dec 2025 SCHEDULE 13G/A Report for Kestra Medical Technologies, Ltd. Common Shares, par value $1.00 per share (KMTS)

Filing Manager
Endeavour Medtech Growth II LP
Reporting Manager
Endeavour Medtech Growth II LP
Security
Kestra Medical Technologies, Ltd. Common Shares, par value $1.00 per share
Symbol
KMTS
Shares outstanding
58,308,143 shares
Disclosed Ownership
2,448,942 shares
Ownership
4.2%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 16:00:06 UTC
Date of event
31 Dec 2025
Previous filing
15 May 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Endeavour Medtech Growth II LP disclosed 4.2% ownership in Kestra Medical Technologies, Ltd. Common Shares, par value $1.00 per share (KMTS) on 31 Dec 2025."

Quick Takeaways

  • Endeavour Medtech Growth II LP filed SCHEDULE 13G/A for Kestra Medical Technologies, Ltd. Common Shares, par value $1.00 per share (KMTS).
  • Disclosed ownership: 4.2%.
  • Date of event: 31 Dec 2025.

What Changed

  • Previous schedule filing date: 15 May 2025.
  • Current filing was accepted on 17 Feb 2026, 16:00.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Endeavour Medtech Growth II LP 4.2% 2,448,942 0 2,448,942 /s/ Nick Barton Nick Barton / Director of Endeavour Medtech II GP Limited, its General Partner
Endeavour Medtech Growth II Parallel LP 4.2% 2,448,942 0 2,448,942 /s/ Nick Barton Nick Barton / Director of Endeavour Medtech II GP Limited, its General Partner
Endeavour Medtech II GP Limited 4.2% 2,448,942 0 2,448,942 /s/ Nick Barton Nick Barton / Director

Sponsored